市場調查報告書
商品編碼
1619012
高價值植物化合物的全球市場:原料·類型·各用途的預測 (~2032年)Global High Value Plant Compound Market Research Report Information by Source, Type, Application, Forecast Till 2032 |
預計全球高價值植物化合物市場規模將從 2023 年的 165.367 億美元增長到 2032 年的 447.247 億美元,預測期內複合年增長率為 11.69%。
對植物性補充劑和營養補充劑的需求是由全球健康和保健趨勢所推動的。促進整體健康和解決健康問題的營養保健品是使用優質植物化合物製成的。藥品、營養品、化妝品、食品和飲料等各行業對天然和有機產品的需求是全球高價值植物化合物市場的主要推動因素。由於消費者對這些化合物的健康益處的認識不斷提高,以及對天然產品勝過合成產品的日益偏好,因此該市場不斷增長。然而,市場面臨課題,包括提取過程的高成本、監管障礙以及對植物材料可持續採購的擔憂。由於提取技術的技術進步以及對研發活動的關注,預計市場進入者將獲得利潤豐厚的機會。
區域展望
2022年北美地區規模最大,市場規模達43億美元。預計 2022 年至 2032 年將以 11.21% 的複合年增長率顯著成長。人們對自然療法、營養補充品和保健產品的興趣日益濃厚,是推動北美高價值植物化合物市場擴張的主要因素。
預計 2022 年歐洲的規模將達到 34 億美元,並在預測期內以 10.74% 的複合年增長率持續增長。市場擴張歸因於歐洲消費者對高價值植物化合物的採用,特別是在化妝品和營養補充劑方面。
到 2022 年,亞太地區的市場規模將達到 67 億美元,預計在預測期內複合年增長率為 12.02%。該地區強勁的複合年增長率歸因於草藥和阿育吠陀療法在製藥和食品行業的廣泛採用,以及這些療法在印度和中國等國家的日益普及。
本報告提供全球高價值植物化合物的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,各種區分·地區/各主要國家的明細,競爭環境,主要企業簡介等資訊。
Global High Value Plant Compound Market Research Report Information by Source (Leaves, Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, Other Sources), Type (Phenylpropanoids, Alkaloids, Terpenoids, Polyketides), Application (Pharmaceuticals, Cosmetics, Food & Beverages, Dietary Supplements, Others, Forecast Till 2032
In 2023, the High Value Plant Compound Market Size was estimated to be USD 16,536.70 million. The Global High Value Plant Compound industry is anticipated to experience a compound annual growth rate (CAGR) of 11.69% from 2024 to 2032, resulting in a total value of USD 44,724.70 million.
The demand for plant-based supplements and nutraceuticals is being driven by the global health and wellness trend. Dietary supplements that promote overall health and address health issues are prepared using high-quality plant compounds. The demand for natural and organic products in a variety of industries, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages, is the primary driver of the global high-value plant compounds market. The market has experienced growth as a result of the increasing consumer awareness of the health benefits of these compounds and the increasing preference for natural products over synthetic ones. Nevertheless, the market is confronted with a variety of obstacles, including the high cost of extraction processes, regulatory obstacles, and concerns regarding the sustainable procurement of plant materials. It is anticipated that market participants will experience lucrative opportunities as a result of technological advancements in extraction techniques and a focus on research and development activities.
Market segment insights
Table 1 illustrates a substantial upward trajectory in the global market for high-value plant compounds from 2022 to 2032. The market, which was valued at USD 14,919.4 million in 2022, is expected to experience a Compound Annual Growth Rate (CAGR) of 11.7% from 2023 to 2032, culminating in a spectacular USD 44,724.7 million in 2032. These compounds, which are derived from a variety of plant sources, are of significant value because they are used in industries such as pharmaceuticals, cosmetics, and food.
Leaves comprise the greatest portion of this market among the various plant sources. Leaves generated USD 4,730.6 million in 2022, and this sector is anticipated to expand at a compound annual growth rate (CAGR) of 11.8%. The substantial increase in the leaves category can be attributed to the growing demand for herbal and botanical constituents in healthcare and wellness products. Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, and Other Sources are also significant contributors to this market, with CAGRs of 12.2%, 10.7%, 12.0%, and 11.5%, respectively.
One of the fastest-growing segments in the market is phenylpropanoids, including curcumin and resveratrol, with a compound annual growth rate (CAGR) of 11.7%. The antioxidant and anti-inflammatory properties of these compounds have made them a popular ingredient in dietary supplements and cosmetic products. Alkaloids and terpenoids are also positioned for significant growth, with anticipated compound annual growth rates (CAGRs) of 11.8% and 11.6%, respectively.
Regional Perspectives
In 2022, North America was the greatest market, with a market valuation of $4.3 billion. between 2022 and 2032, the region experienced substantial growth, with a Compound Annual Growth Rate (CAGR) of 11.21%. The burgeoning interest in natural remedies, dietary supplements, and wellness products is the primary factor driving the expansion of the high-value plant compounds market in North America.
Europe, which had a market value of $3.4 billion in 2022, exhibited a compound annual growth rate (CAGR) of 10.74% during the same period, indicating consistent growth. The market has expanded because of the adoption of high-value plant compounds by European consumers, particularly in cosmetics and dietary supplements.
The market value of $6.7 billion in 2022 was achieved by the Asia-Pacific region, which exhibited the maximum CAGR at 12.02% during the same period. The region's robust CAGR can be attributed to the extensive adoption of herbal and Ayurvedic remedies in the pharmaceutical and food industries, as well as the increasing popularity of these remedies in countries such as India and China.
Merck KGaA, MedChemExpress, Selleck Chemicals, Biosynth, Tokyo Chemical Industry, Advion, Inc, Alkaloids Corporation, C-Squared Pharma S.a R.L., Linnea SA, and Inga Pharmaceuticals are among the key companies in the High Value Plant Compound market.